Each year, the American Association for Cancer Research (AACR) publishes an annual report to Congress and the American public highlighting how biomedical research extends and improves lives by accelerating advances in cancer prevention, detection, diagnosis, and treatment. Over the past decade, immunotherapy has become an increasingly central component of the report as the number of immunotherapies approved by the FDA has grown. The incredible progress that has been made in using immunotherapy for the benefit of patients with cancer is celebrated in the latest edition of the report—AACR Cancer Progress Report 2023 (freely available at https://cancerprogressreport.aacr.org/progress/)—with a dedicated section titled, “Immunotherapy: Pushing the Frontier of Cancer Medicine.” As part of that special feature, we provide a perspective on the advances that have been made in the use of immune checkpoint therapy (ICT) and on the approaches that we believe will bring more breakthroughs in ICT, in the form...
Skip Nav Destination
Article navigation
Editorial|
September 13 2023
Cancer Immunology and Immunotherapy Showcased in the AACR Cancer Progress Report 2023
Padmanee Sharma
;
Padmanee Sharma
*
1Senior Editor, Cancer Immunology Research.
*Corresponding Author: Padmanee Sharma, Genitourinary Medical Oncology and Immunology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, 77030, United States. E-mail: PadSharma@mdanderson.org
Search for other works by this author on:
James P. Allison
James P. Allison
2Deputy Editor, Cancer Immunology Research.
Search for other works by this author on:
*Corresponding Author: Padmanee Sharma, Genitourinary Medical Oncology and Immunology, The University of Texas MD Anderson Cancer Center, 1515 Holcombe Blvd, Houston, 77030, United States. E-mail: PadSharma@mdanderson.org
Cancer Immunol Res 2023;XX:XX–XX
Received:
August 17 2023
Accepted:
August 22 2023
Online ISSN: 2326-6074
Print ISSN: 2326-6066
©2023 American Association for Cancer Research
2023
American Association for Cancer Research
Cancer Immunol Res OF1–OF2.
Article history
Received:
August 17 2023
Accepted:
August 22 2023
Citation
Padmanee Sharma, James P. Allison; Cancer Immunology and Immunotherapy Showcased in the AACR Cancer Progress Report 2023. Cancer Immunol Res 2023; https://doi.org/10.1158/2326-6066.CIR-23-0672
Download citation file:
Sign in
Don't already have an account? Register
Client Account
You could not be signed in. Please check your email address / username and password and try again.
Could not validate captcha. Please try again.
Pay-Per-View 24-Hour Access
$50.00
85
Views
Cited by
Advertisement
Email alerts
Related Articles
Checkpoint Blockade + Chemotherapy: the Right Combination for AML?
Blood Cancer Discov (November,2021)
Exercise Training Reduces the Inflammatory Response and Promotes Intestinal Mucosa-Associated Immunity in Lynch Syndrome
Clin Cancer Res (September,2023)
The Immunological Synapse
Cancer Immunol Res (November,2014)
Botanicals as immunological adjuvants
Cancer Res (May,2007)